284 is the total number of securities Affinity Asset Advisors, LLC has owned. The longest Affinity Asset Advisors, LLC has owned a single stock is 12 quarters.
| Period | Weighting | Quarter | |||||||
|---|---|---|---|---|---|---|---|---|---|
| Ticker | Name | Longest | Shortest | Min. | Avg. | Max. | First | Latest | ↓ Count |
| MORF | MORPHIC HOLDING INC | 12 | 12 | 1.16% | 3.14% | 6.87% | Q4 2020 | Q3 2023 | 12 |
| KURA | KURA ONCOLOGY INC | 12 | 12 | 1.31% | 3.08% | 7.17% | Q4 2020 | Q3 2023 | 12 |
| CLDX | CELLDEX THERAPEUTICS I... | 12 | 12 | 0.45% | 0.89% | 1.92% | Q4 2020 | Q3 2023 | 12 |
| IMTXW | IMMATICS N.V | 12 | 12 | 0.05% | 0.20% | 0.37% | Q4 2020 | Q3 2023 | 12 |
| KDNY | CHINOOK THERAPEUTICS INC | 11 | 11 | 0.24% | 3.68% | 8.40% | Q4 2020 | Q2 2023 | 11 |
| ESTA | ESTABLISHMENT LABS HLD... | 11 | 11 | 0.21% | 3.16% | 8.25% | Q1 2021 | Q3 2023 | 11 |
| VINC | VINCERX PHARMA INC | 11 | 11 | 0.51% | 2.20% | 4.47% | Q4 2020 | Q2 2023 | 11 |
| ASND | ASCENDIS PHARMA A/S | 7 | 4 | 0.88% | 2.00% | 4.90% | Q4 2020 | Q3 2023 | 11 |
| CYTK | CYTOKINETICS INC | 6 | 5 | 0.25% | 1.25% | 2.57% | Q4 2020 | Q3 2023 | 11 |
| NARI | INARI MED INC | 10 | 10 | 0.41% | 2.67% | 6.37% | Q4 2020 | Q1 2023 | 10 |
| CERE | CEREVEL THERAPEUTICS H... | 6 | 4 | 0.39% | 2.65% | 6.11% | Q4 2020 | Q3 2023 | 10 |
| MDGL | MADRIGAL PHARMACEUTICA... | 8 | 1 | 0.30% | 3.85% | 7.97% | Q4 2020 | Q3 2023 | 9 |
| RCKT | ROCKET PHARMACEUTICALS... | 9 | 9 | 0.61% | 1.50% | 3.05% | Q4 2020 | Q4 2022 | 9 |
| BLU | BELLUS HEALTH INC NEW | 9 | 9 | 0.33% | 1.21% | 2.09% | Q1 2021 | Q1 2023 | 9 |
| CNTA | CENTESSA PHARMACEUTICA... | 5 | 4 | 0.09% | 0.97% | 1.95% | Q2 2021 | Q3 2023 | 9 |
| BBIO | BRIDGEBIO PHARMA INC | 5 | 3 | 0.21% | 5.36% | 12.08% | Q4 2020 | Q3 2023 | 8 |
| TRAVERE THERAPEUTICS INC | 8 | 8 | 1.38% | 2.47% | 4.60% | Q4 2020 | Q3 2022 | 8 | |
| CBAY | CYMABAY THERAPEUTICS INC | 8 | 8 | 0.63% | 2.46% | 4.74% | Q4 2021 | Q3 2023 | 8 |
| BRIDGEBIO PHARMA INC | 8 | 8 | 0.70% | 2.18% | 4.62% | Q4 2021 | Q3 2023 | 8 | |
| SWTX | SPRINGWORKS THERAPEUTI... | 5 | 1 | 0.27% | 1.90% | 6.72% | Q1 2021 | Q3 2023 | 8 |
| HZNP | HORIZON THERAPEUTICS P... | 4 | 2 | 0.42% | 1.23% | 2.52% | Q4 2020 | Q1 2023 | 8 |
| KALV | KALVISTA PHARMACEUTICA... | 5 | 3 | 0.39% | 0.56% | 0.87% | Q4 2020 | Q3 2023 | 8 |
| PCVX | VAXCYTE INC | 4 | 4 | 0.20% | 0.48% | 1.13% | Q4 2020 | Q3 2023 | 8 |
| LIANBIO SPONSORED | 8 | 8 | 0.16% | 0.35% | 0.64% | Q4 2021 | Q3 2023 | 8 | |
| CRIS | CURIS INC | 7 | 7 | 0.13% | 2.08% | 6.30% | Q4 2020 | Q2 2022 | 7 |
| ZNTL | ZENTALIS PHARMACEUTICA... | 7 | 7 | 0.83% | 1.73% | 3.59% | Q1 2021 | Q3 2022 | 7 |
| AZN | ASTRAZENECA PLC | 7 | 7 | 1.14% | 1.71% | 2.37% | Q1 2022 | Q3 2023 | 7 |
| ACRS | ACLARIS THERAPEUTICS INC | 7 | 7 | 0.28% | 1.26% | 2.11% | Q1 2021 | Q3 2022 | 7 |
| XENE | XENON PHARMACEUTICALS INC | 4 | 3 | 0.19% | 1.12% | 2.89% | Q3 2021 | Q3 2023 | 7 |
| ALDX | ALDEYRA THERAPEUTICS INC | 5 | 2 | 0.08% | 0.50% | 1.21% | Q4 2020 | Q3 2023 | 7 |
| MSACW | MEDICUS SCIENCES ACQUI... | 7 | 7 | 0.00% | 0.00% | 0.01% | Q2 2021 | Q4 2022 | 7 |
| ARCELLX INC | 6 | 6 | 0.57% | 2.20% | 4.04% | Q2 2022 | Q3 2023 | 6 | |
| LNTH | LANTHEUS HLDGS INC | 5 | 1 | 0.59% | 1.68% | 3.90% | Q1 2022 | Q3 2023 | 6 |
| NAUT | NAUTILUS BIOTECHNOLOGY... | 6 | 6 | 0.22% | 1.31% | 3.25% | Q2 2021 | Q3 2022 | 6 |
| GBT | GLOBAL BLOOD THERAPEUT... | 4 | 1 | 0.25% | 1.03% | 3.61% | Q4 2020 | Q3 2022 | 6 |
| HSAQ | HEALTH SCIENCES ACQUIS... | 6 | 6 | 0.48% | 0.94% | 1.36% | Q4 2020 | Q1 2022 | 6 |
| IOVA | IOVANCE BIOTHERAPEUTIC... | 5 | 1 | 0.14% | 0.62% | 0.94% | Q4 2020 | Q4 2022 | 6 |
| CYCC | CYCLACEL PHARMACEUTICA... | 6 | 6 | 0.20% | 0.58% | 0.92% | Q4 2020 | Q1 2022 | 6 |
| CONTEXT THERAPEUTICS INC | 4 | 2 | 0.14% | 0.31% | 0.79% | Q1 2022 | Q3 2023 | 6 | |
| SPY | SPDR S&P 500 ETF TRUST... | 2 | 1 | 7.93% | 22.54% | 54.19% | Q4 2020 | Q3 2022 | 5 |
| VRNA | VERONA PHARMA PLC | 5 | 5 | 1.00% | 2.44% | 3.30% | Q3 2022 | Q3 2023 | 5 |
| ASTRIA THERAPEUTICS INC | 5 | 5 | 1.01% | 2.02% | 2.76% | Q3 2022 | Q3 2023 | 5 | |
| ARYA SCIENCES ACQUISIT... | 5 | 5 | 0.97% | 1.55% | 2.47% | Q3 2021 | Q3 2022 | 5 | |
| BRIDGEBIO PHARMA INC | 5 | 5 | 0.75% | 1.53% | 2.35% | Q1 2022 | Q1 2023 | 5 | |
| VKTX | VIKING THERAPEUTICS INC | 5 | 5 | 0.19% | 1.51% | 3.42% | Q3 2022 | Q3 2023 | 5 |
| TVTX | TRAVERE THERAPEUTICS INC | 3 | 1 | 0.25% | 0.86% | 1.86% | Q1 2021 | Q3 2023 | 5 |
| RENOVACOR INC | 5 | 5 | 0.14% | 0.21% | 0.35% | Q3 2021 | Q3 2022 | 5 | |
| RENOVACOR INC | 5 | 5 | 0.00% | 0.01% | 0.02% | Q3 2021 | Q3 2022 | 5 | |
| ARKG | ARK ETF TR | 3 | 1 | 1.96% | 4.65% | 7.45% | Q4 2020 | Q3 2023 | 4 |
| XLRN | ACCELERON PHARMA INC | 4 | 4 | 1.54% | 2.28% | 3.05% | Q4 2020 | Q3 2021 | 4 |
| VENTYX BIOSCIENCES INC | 4 | 4 | 1.15% | 2.20% | 3.09% | Q3 2022 | Q2 2023 | 4 | |
| ARYD | ARYA SCIENCES ACQU COR... | 4 | 4 | 1.44% | 2.04% | 2.69% | Q1 2021 | Q4 2021 | 4 |
| OCUL | OCULAR THERAPEUTIX INC | 4 | 4 | 1.27% | 1.71% | 2.41% | Q4 2020 | Q3 2021 | 4 |
| PTGX | PROTAGONIST THERAPEUTI... | 2 | 2 | 0.44% | 1.71% | 2.99% | Q1 2021 | Q1 2022 | 4 |
| NVAX | NOVAVAX INC | 2 | 1 | 0.79% | 1.54% | 2.60% | Q4 2021 | Q1 2023 | 4 |
| INZY | INOZYME PHARMA INC | 4 | 4 | 0.21% | 1.18% | 1.63% | Q4 2022 | Q3 2023 | 4 |
| MRTX | MIRATI THERAPEUTICS INC | 2 | 1 | 0.74% | 1.05% | 1.23% | Q4 2020 | Q3 2023 | 4 |
| LSAQ | LIFESCI ACQUISITION II... | 4 | 4 | 0.37% | 1.00% | 1.70% | Q4 2020 | Q3 2021 | 4 |
| MRNA | MODERNA INC | 2 | 1 | 0.22% | 0.99% | 1.77% | Q1 2021 | Q1 2023 | 4 |
| MREO | MEREO BIOPHARMA GROUP PLC | 4 | 4 | 0.40% | 0.84% | 1.19% | Q4 2020 | Q3 2021 | 4 |
| MSAC | MEDICUS SCIENCES ACQUI... | 4 | 4 | 0.47% | 0.83% | 1.06% | Q2 2021 | Q1 2022 | 4 |
| ZYME | ZYMEWORKS INC | 4 | 4 | 0.28% | 0.79% | 1.63% | Q4 2020 | Q3 2021 | 4 |
| PNT | POINT BIOPHARMA GLOBAL... | 4 | 4 | 0.07% | 0.73% | 1.61% | Q2 2022 | Q1 2023 | 4 |
| LUNG | PULMONX CORPORATION | 4 | 4 | 0.23% | 0.65% | 0.95% | Q4 2020 | Q3 2021 | 4 |
| MRSN | MERSANA THERAPEUTICS INC | 3 | 1 | 0.41% | 0.65% | 1.02% | Q4 2020 | Q3 2023 | 4 |
| COGT | COGENT BIOSCIENCES INC | 4 | 4 | 0.48% | 0.63% | 0.88% | Q2 2022 | Q1 2023 | 4 |
| PRECIGEN INC | 4 | 4 | 0.41% | 0.50% | 0.58% | Q3 2022 | Q2 2023 | 4 | |
| ALPN | ALPINE IMMUNE SCIENCES... | 4 | 4 | 0.22% | 0.50% | 0.72% | Q3 2022 | Q2 2023 | 4 |
| APLS | APELLIS PHARMACEUTICAL... | 3 | 1 | 0.23% | 0.43% | 0.76% | Q2 2021 | Q3 2023 | 4 |
| NRIX | NURIX THERAPEUTICS INC | 4 | 4 | 0.34% | 0.42% | 0.55% | Q4 2022 | Q3 2023 | 4 |
| MIRM | MIRUM PHARMACEUTICALS INC | 4 | 4 | 0.27% | 0.40% | 0.75% | Q4 2022 | Q3 2023 | 4 |
| AXSM | AXSOME THERAPEUTICS INC | 3 | 1 | 0.19% | 0.39% | 0.60% | Q4 2020 | Q2 2023 | 4 |
| BCAB | BIOATLA INC | 4 | 4 | 0.09% | 0.30% | 0.48% | Q4 2022 | Q3 2023 | 4 |
| MIST | MILESTONE PHARMACEUTIC... | 4 | 4 | 0.16% | 0.25% | 0.30% | Q4 2022 | Q3 2023 | 4 |
| NUVB | NUVATION BIO INC | 4 | 4 | 0.09% | 0.14% | 0.19% | Q4 2022 | Q3 2023 | 4 |
| RXDX | PROMETHEUS BIOSCIENCES... | 3 | 3 | 0.41% | 2.99% | 5.31% | Q3 2022 | Q1 2023 | 3 |
| NANOSTRING TECHNOLOGIE... | 3 | 3 | 1.24% | 2.34% | 3.38% | Q1 2022 | Q3 2022 | 3 | |
| IMVT | IMMUNOVANT INC | 2 | 1 | 1.72% | 2.27% | 3.24% | Q4 2020 | Q3 2023 | 3 |
| RPTX | REPARE THERAPEUTICS INC | 3 | 3 | 1.07% | 1.68% | 2.08% | Q4 2021 | Q2 2022 | 3 |
| VKTX | VIKING THERAPEUTICS INC | 3 | 3 | 0.52% | 1.18% | 1.98% | Q1 2023 | Q3 2023 | 3 |
| KRTX | KARUNA THERAPEUTICS INC | 2 | 1 | 0.15% | 1.10% | 2.40% | Q1 2022 | Q1 2023 | 3 |
| LNTH | LANTHEUS HLDGS INC | 3 | 3 | 0.35% | 0.96% | 1.95% | Q1 2022 | Q3 2022 | 3 |
| ESPERION THERAPEUTICS ... | 3 | 3 | 0.54% | 0.91% | 1.20% | Q4 2022 | Q2 2023 | 3 | |
| NSTG | NANOSTRING TECHNOLOGIE... | 2 | 1 | 0.35% | 0.74% | 0.95% | Q2 2021 | Q1 2022 | 3 |
| SGEN | SEAGEN INC | 2 | 1 | 0.25% | 0.73% | 1.34% | Q4 2022 | Q3 2023 | 3 |
| NTLA | INTELLIA THERAPEUTICS INC | 3 | 3 | 0.43% | 0.51% | 0.58% | Q2 2021 | Q4 2021 | 3 |
| BFLY | BUTTERFLY NETWORK INC | 3 | 3 | 0.40% | 0.50% | 0.57% | Q1 2021 | Q3 2021 | 3 |
| BCTG | BCTG ACQUISITION CORP | 3 | 3 | 0.38% | 0.46% | 0.61% | Q4 2020 | Q2 2021 | 3 |
| THESEUS PHARMACEUTICAL... | 3 | 3 | 0.29% | 0.46% | 0.78% | Q1 2023 | Q3 2023 | 3 | |
| TANGO THERAPEUTICS INC | 1 | 1 | 0.08% | 0.45% | 1.11% | Q3 2021 | Q3 2023 | 3 | |
| AFIB | ACUTUS MED INC | 3 | 3 | 0.27% | 0.40% | 0.49% | Q1 2021 | Q3 2021 | 3 |
| ADCT | ADC THERAPEUTICS SA | 3 | 3 | 0.28% | 0.37% | 0.45% | Q1 2023 | Q3 2023 | 3 |
| SCIENCE 37 HOLDINGS INC | 3 | 3 | 0.19% | 0.37% | 0.68% | Q4 2021 | Q2 2022 | 3 | |
| GLPG | GALAPAGOS NV | 3 | 3 | 0.27% | 0.36% | 0.50% | Q1 2021 | Q3 2021 | 3 |
| HARP | HARPOON THERAPEUTICS INC | 3 | 3 | 0.14% | 0.30% | 0.50% | Q1 2021 | Q3 2021 | 3 |
| CEREW | CEREVEL THERAPEUTICS H... | 3 | 3 | 0.11% | 0.23% | 0.37% | Q4 2020 | Q2 2021 | 3 |
| ACHL | ACHILLES THERAPEUTICS PLC | 3 | 3 | 0.14% | 0.21% | 0.28% | Q1 2021 | Q3 2021 | 3 |
| PBYI | PUMA BIOTECHNOLOGY INC | 3 | 3 | 0.15% | 0.19% | 0.25% | Q1 2023 | Q3 2023 | 3 |
| IMVT | IMMUNOVANT INC | 3 | 3 | 0.07% | 0.19% | 0.38% | Q1 2021 | Q3 2021 | 3 |
| CTMX | CYTOMX THERAPEUTICS INC | 3 | 3 | 0.13% | 0.15% | 0.17% | Q1 2021 | Q3 2021 | 3 |
| NLSP | NLS PHARMACEUTICS LTD | 3 | 3 | 0.04% | 0.12% | 0.17% | Q1 2023 | Q3 2023 | 3 |
| NEWAMSTERDAM PHARMA CO... | 3 | 3 | 0.02% | 0.04% | 0.07% | Q1 2023 | Q3 2023 | 3 | |
| ROCKET PHARMACEUTICALS... | 3 | 3 | 0.00% | 0.00% | 0.01% | Q1 2023 | Q3 2023 | 3 | |
| XBI | SPDR SER TR | 2 | 2 | 9.69% | 15.96% | 22.22% | Q2 2021 | Q3 2021 | 2 |
| TEVA | TEVA PHARMACEUTICAL IN... | 2 | 2 | 4.21% | 4.97% | 5.74% | Q2 2023 | Q3 2023 | 2 |
| SAVA | CASSAVA SCIENCES INC | 2 | 2 | 1.18% | 3.36% | 5.55% | Q3 2021 | Q4 2021 | 2 |
| ARYA | ARYA SCIENCES ACQUISIT... | 2 | 2 | 1.72% | 2.47% | 3.22% | Q4 2020 | Q1 2021 | 2 |
| MRNA | MODERNA INC | 1 | 1 | 2.11% | 2.44% | 2.77% | Q4 2021 | Q4 2022 | 2 |
| BBIO | BRIDGEBIO PHARMA INC | 2 | 2 | 2.13% | 2.20% | 2.26% | Q1 2023 | Q2 2023 | 2 |
| BMRN | BIOMARIN PHARMACEUTICA... | 2 | 2 | 0.80% | 2.02% | 3.25% | Q4 2022 | Q1 2023 | 2 |
| PRTA | PROTHENA CORP PLC | 2 | 2 | 1.08% | 1.73% | 2.38% | Q2 2023 | Q3 2023 | 2 |
| SNDX | SYNDAX PHARMACEUTICALS... | 2 | 2 | 1.45% | 1.61% | 1.77% | Q4 2020 | Q1 2021 | 2 |
| STRO | SUTRO BIOPHARMA INC | 2 | 2 | 0.62% | 1.46% | 2.30% | Q4 2020 | Q1 2021 | 2 |
| CRIS | CURIS INC | 1 | 1 | 0.96% | 1.39% | 1.82% | Q1 2021 | Q4 2021 | 2 |
| AUTL | AUTOLUS THERAPEUTICS PLC | 2 | 2 | 1.31% | 1.31% | 1.32% | Q2 2023 | Q3 2023 | 2 |
| SNDX | SYNDAX PHARMACEUTICALS... | 1 | 1 | 1.00% | 1.19% | 1.39% | Q4 2021 | Q4 2022 | 2 |
| CRSP | CRISPR THERAPEUTICS AG | 2 | 2 | 0.55% | 1.17% | 1.79% | Q1 2022 | Q2 2022 | 2 |
| ARGX | ARGENX SE | 2 | 2 | 0.74% | 1.03% | 1.32% | Q4 2022 | Q1 2023 | 2 |
| VRDN | VIRIDIAN THERAPEUTICS INC | 2 | 2 | 0.84% | 0.96% | 1.08% | Q1 2023 | Q2 2023 | 2 |
| IMTX | IMMATICS N.V | 2 | 2 | 0.65% | 0.93% | 1.21% | Q2 2023 | Q3 2023 | 2 |
| ENVI | ENVIRONMENTAL IMPACT A... | 2 | 2 | 0.75% | 0.92% | 1.08% | Q3 2021 | Q4 2021 | 2 |
| PROCEPT BIOROBOTICS CORP | 2 | 2 | 0.76% | 0.83% | 0.91% | Q3 2021 | Q4 2021 | 2 | |
| EPIX | ESSA PHARMA INC | 2 | 2 | 0.72% | 0.80% | 0.89% | Q1 2021 | Q2 2021 | 2 |
| KPTI | KARYOPHARM THERAPEUTIC... | 2 | 2 | 0.59% | 0.74% | 0.88% | Q4 2022 | Q1 2023 | 2 |
| GERN | GERON CORP | 2 | 2 | 0.42% | 0.71% | 1.00% | Q3 2022 | Q4 2022 | 2 |
| GERN | GERON CORP | 2 | 2 | 0.41% | 0.60% | 0.79% | Q3 2022 | Q4 2022 | 2 |
| GOSSAMER BIO INC | 2 | 2 | 0.53% | 0.55% | 0.58% | Q2 2021 | Q3 2021 | 2 | |
| MGNX | MACROGENICS INC | 2 | 2 | 0.27% | 0.52% | 0.77% | Q1 2021 | Q2 2021 | 2 |
| SDGR | SCHRODINGER INC | 2 | 2 | 0.34% | 0.51% | 0.68% | Q2 2021 | Q3 2021 | 2 |
| RFL | RAFAEL HLDGS INC | 2 | 2 | 0.19% | 0.49% | 0.78% | Q3 2021 | Q4 2021 | 2 |
| TERN | TERNS PHARMACEUTICALS INC | 1 | 1 | 0.42% | 0.44% | 0.46% | Q2 2022 | Q3 2023 | 2 |
| SEER | SEER INC | 2 | 2 | 0.41% | 0.42% | 0.44% | Q3 2021 | Q4 2021 | 2 |
| NEWAMSTERDAM PHARMA CO... | 2 | 2 | 0.32% | 0.37% | 0.42% | Q2 2023 | Q3 2023 | 2 | |
| ROIVANT SCIENCES LTD | 1 | 1 | 0.24% | 0.37% | 0.49% | Q1 2023 | Q3 2023 | 2 | |
| MINERALYS THERAPEUTICS... | 2 | 2 | 0.32% | 0.35% | 0.37% | Q1 2023 | Q2 2023 | 2 | |
| BYSI | BEYONDSPRING INC | 2 | 2 | 0.19% | 0.34% | 0.48% | Q4 2020 | Q1 2021 | 2 |
| IFRX | INFLARX NV | 2 | 2 | 0.27% | 0.32% | 0.37% | Q2 2023 | Q3 2023 | 2 |
| VINCW | VINCERX PHARMA INC | 2 | 2 | 0.30% | 0.32% | 0.33% | Q4 2020 | Q1 2021 | 2 |
| CCCC | C4 THERAPEUTICS INC | 2 | 2 | 0.25% | 0.30% | 0.35% | Q4 2020 | Q1 2021 | 2 |
| CHAQU | CHARDAN HEALTHCR ACQST... | 2 | 2 | 0.27% | 0.28% | 0.29% | Q1 2021 | Q2 2021 | 2 |
| FHTX | FOGHORN THERAPEUTICS INC | 2 | 2 | 0.28% | 0.28% | 0.28% | Q4 2022 | Q1 2023 | 2 |
| TALS | TALARIS THERAPEUTICS INC | 2 | 2 | 0.21% | 0.26% | 0.32% | Q2 2023 | Q3 2023 | 2 |
| JASPER THERAPEUTICS INC | 2 | 2 | 0.23% | 0.26% | 0.28% | Q1 2023 | Q2 2023 | 2 | |
| CELULARITY INC | 2 | 2 | 0.11% | 0.19% | 0.26% | Q1 2022 | Q2 2022 | 2 | |
| ETNB | 89BIO INC | 1 | 1 | 0.16% | 0.17% | 0.18% | Q1 2023 | Q3 2023 | 2 |
| ASLN | ASLAN PHARMACEUTICALS LTD | 1 | 1 | 0.11% | 0.17% | 0.23% | Q1 2021 | Q3 2021 | 2 |
| VRDN | VIRIDIAN THERAPEUTICS INC | 2 | 2 | 0.10% | 0.12% | 0.15% | Q1 2022 | Q2 2022 | 2 |
| HYPERFINE INC | 2 | 2 | 0.04% | 0.12% | 0.20% | Q4 2021 | Q1 2022 | 2 | |
| SKINW | THE BEAUTY HEALTH COMPANY | 2 | 2 | 0.10% | 0.11% | 0.13% | Q2 2021 | Q3 2021 | 2 |
| VSPRW | VESPER HEALTHCARE ACQU... | 2 | 2 | 0.03% | 0.04% | 0.05% | Q4 2020 | Q1 2021 | 2 |
| ZYNE | ZYNERBA PHARMACEUTICAL... | 2 | 2 | 0.02% | 0.02% | 0.02% | Q4 2020 | Q1 2021 | 2 |
| SCILEX HOLDING CO | 2 | 2 | 0.00% | 0.00% | 0.01% | Q4 2022 | Q1 2023 | 2 | |
| SCILEX HOLDING CO | 2 | 2 | 0.00% | 0.00% | 0.00% | Q4 2022 | Q1 2023 | 2 | |
| EIDX | EIDOS THERAPEUTICS INC | 1 | 1 | 15.69% | 15.69% | 15.69% | Q4 2020 | Q4 2020 | 1 |
| APOGEE THERAPEUTICS INC | 1 | 1 | 6.26% | 6.26% | 6.26% | Q3 2023 | Q3 2023 | 1 | |
| SPY | SPDR S&P 500 ETF TRTR ... | 1 | 1 | 6.08% | 6.08% | 6.08% | Q1 2023 | Q1 2023 | 1 |
| BMY | BRISTOL MYERS SQUIBB CO | 1 | 1 | 4.94% | 4.94% | 4.94% | Q4 2022 | Q4 2022 | 1 |
| MDGL | MADRIGAL PHARMACEUTICA... | 1 | 1 | 4.28% | 4.28% | 4.28% | Q2 2023 | Q2 2023 | 1 |
| MRK | MERCK & CO INC | 1 | 1 | 4.21% | 4.21% | 4.21% | Q1 2023 | Q1 2023 | 1 |
| LLY | LILLY ELI & CO | 1 | 1 | 4.10% | 4.10% | 4.10% | Q2 2022 | Q2 2022 | 1 |
| BIIB | BIOGEN INC | 1 | 1 | 3.98% | 3.98% | 3.98% | Q2 2023 | Q2 2023 | 1 |
| CVAC | CUREVAC N V | 1 | 1 | 3.95% | 3.95% | 3.95% | Q2 2021 | Q2 2021 | 1 |
| CRNX | CRINETICS PHARMACEUTIC... | 1 | 1 | 3.76% | 3.76% | 3.76% | Q3 2023 | Q3 2023 | 1 |
| VRTX | VERTEX PHARMACEUTICALS... | 1 | 1 | 3.65% | 3.65% | 3.65% | Q1 2021 | Q1 2021 | 1 |
| ESTA | ESTABLISHMENT LABS HLD... | 1 | 1 | 3.44% | 3.44% | 3.44% | Q2 2022 | Q2 2022 | 1 |
| ARNA | ARENA PHARMACEUTICALS INC | 1 | 1 | 3.38% | 3.38% | 3.38% | Q4 2021 | Q4 2021 | 1 |
| IWM | ISHARES TR | 1 | 1 | 3.22% | 3.22% | 3.22% | Q3 2022 | Q3 2022 | 1 |
| SNY | SANOFI | 1 | 1 | 3.18% | 3.18% | 3.18% | Q3 2022 | Q3 2022 | 1 |
| TEVA | TEVA PHARMACEUTICAL IN... | 1 | 1 | 3.16% | 3.16% | 3.16% | Q3 2023 | Q3 2023 | 1 |
| SNY | SANOFI | 1 | 1 | 2.65% | 2.65% | 2.65% | Q3 2022 | Q3 2022 | 1 |
| KRTX | KARUNA THERAPEUTICS INC | 1 | 1 | 2.40% | 2.40% | 2.40% | Q2 2022 | Q2 2022 | 1 |
| AMGN | AMGEN INC | 1 | 1 | 2.06% | 2.06% | 2.06% | Q4 2022 | Q4 2022 | 1 |
| ESTA | ESTABLISHMENT LABS HLD... | 1 | 1 | 1.93% | 1.93% | 1.93% | Q3 2023 | Q3 2023 | 1 |
| KRYS | KRYSTAL BIOTECH INC | 1 | 1 | 1.88% | 1.88% | 1.88% | Q3 2023 | Q3 2023 | 1 |
| NVAX | NOVAVAX INC | 1 | 1 | 1.84% | 1.84% | 1.84% | Q2 2022 | Q2 2022 | 1 |
| CLDX | CELLDEX THERAPEUTICS I... | 1 | 1 | 1.65% | 1.65% | 1.65% | Q2 2022 | Q2 2022 | 1 |
| ALKS | ALKERMES PLC | 1 | 1 | 1.58% | 1.58% | 1.58% | Q3 2023 | Q3 2023 | 1 |
| AZN | ASTRAZENECA PLC | 1 | 1 | 1.53% | 1.53% | 1.53% | Q3 2022 | Q3 2022 | 1 |
| ALNY | ALNYLAM PHARMACEUTICAL... | 1 | 1 | 1.52% | 1.52% | 1.52% | Q2 2021 | Q2 2021 | 1 |
| SWTX | SPRINGWORKS THERAPEUTI... | 1 | 1 | 1.44% | 1.44% | 1.44% | Q1 2022 | Q1 2022 | 1 |
| APLS | APELLIS PHARMACEUTICAL... | 1 | 1 | 1.39% | 1.39% | 1.39% | Q3 2023 | Q3 2023 | 1 |
| IMVT | IMMUNOVANT INC | 1 | 1 | 1.38% | 1.38% | 1.38% | Q3 2023 | Q3 2023 | 1 |
| MDGL | MADRIGAL PHARMACEUTICA... | 1 | 1 | 1.36% | 1.36% | 1.36% | Q3 2022 | Q3 2022 | 1 |
| PEN | PENUMBRA INC | 1 | 1 | 1.32% | 1.32% | 1.32% | Q3 2022 | Q3 2022 | 1 |
| VRTX | VERTEX PHARMACEUTICALS... | 1 | 1 | 1.25% | 1.25% | 1.25% | Q4 2020 | Q4 2020 | 1 |
| SVRA | SAVARA INC | 1 | 1 | 1.22% | 1.22% | 1.22% | Q3 2023 | Q3 2023 | 1 |
| ATNX | ATHENEX INC | 1 | 1 | 1.17% | 1.17% | 1.17% | Q4 2020 | Q4 2020 | 1 |
| LEGN | LEGEND BIOTECH CORP | 1 | 1 | 1.16% | 1.16% | 1.16% | Q2 2022 | Q2 2022 | 1 |
| AZN | ASTRAZENECA PLC | 1 | 1 | 1.14% | 1.14% | 1.14% | Q1 2023 | Q1 2023 | 1 |
| AXSM | AXSOME THERAPEUTICS INC | 1 | 1 | 1.08% | 1.08% | 1.08% | Q4 2020 | Q4 2020 | 1 |
| LPTX | LEAP THERAPEUTICS INC | 1 | 1 | 1.08% | 1.08% | 1.08% | Q4 2020 | Q4 2020 | 1 |
| VRNA | VERONA PHARMA PLC | 1 | 1 | 1.08% | 1.08% | 1.08% | Q4 2022 | Q4 2022 | 1 |
| IONS | IONIS PHARMACEUTICALS INC | 1 | 1 | 1.07% | 1.07% | 1.07% | Q2 2021 | Q2 2021 | 1 |
| PMVP | PMV PHARMACEUTICALS INC | 1 | 1 | 1.06% | 1.06% | 1.06% | Q1 2022 | Q1 2022 | 1 |
| EDIT | EDITAS MEDICINE INC | 1 | 1 | 1.04% | 1.04% | 1.04% | Q3 2021 | Q3 2021 | 1 |
| RETA | REATA PHARMACEUTICALS INC | 1 | 1 | 1.04% | 1.04% | 1.04% | Q2 2023 | Q2 2023 | 1 |
| ETNB | 89BIO INC | 1 | 1 | 1.00% | 1.00% | 1.00% | Q1 2023 | Q1 2023 | 1 |
| SLDB | SOLID BIOSCIENCES INC | 1 | 1 | 1.00% | 1.00% | 1.00% | Q4 2020 | Q4 2020 | 1 |
| MSACU | MEDICUS SCIENCES ACQUI... | 1 | 1 | 1.00% | 1.00% | 1.00% | Q1 2021 | Q1 2021 | 1 |
| FGEN | FIBROGEN INC | 1 | 1 | 0.93% | 0.93% | 0.93% | Q2 2023 | Q2 2023 | 1 |
| FGEN | FIBROGEN INC | 1 | 1 | 0.93% | 0.93% | 0.93% | Q2 2023 | Q2 2023 | 1 |
| VKTX | VIKING THERAPEUTICS INC | 1 | 1 | 0.92% | 0.92% | 0.92% | Q4 2022 | Q4 2022 | 1 |
| GSK PLC | 1 | 1 | 0.90% | 0.90% | 0.90% | Q3 2022 | Q3 2022 | 1 | |
| TRILLIUM THERAPEUTICS INC | 1 | 1 | 0.89% | 0.89% | 0.89% | Q3 2021 | Q3 2021 | 1 | |
| ASND | ASCENDIS PHARMA A/S | 1 | 1 | 0.88% | 0.88% | 0.88% | Q1 2021 | Q1 2021 | 1 |
| AEGLEA BIOTHERAPEUTICS... | 1 | 1 | 0.84% | 0.84% | 0.84% | Q3 2023 | Q3 2023 | 1 | |
| DVAX | DYNAVAX TECHNOLOGIES CORP | 1 | 1 | 0.83% | 0.83% | 0.83% | Q3 2023 | Q3 2023 | 1 |
| PTGX | PROTAGONIST THERAPEUTI... | 1 | 1 | 0.82% | 0.82% | 0.82% | Q1 2022 | Q1 2022 | 1 |
| MGTX | MEIRAGTX HOLDINGS PLC | 1 | 1 | 0.80% | 0.80% | 0.80% | Q4 2020 | Q4 2020 | 1 |
| MOONLAKE IMMUNOTHERAPE... | 1 | 1 | 0.80% | 0.80% | 0.80% | Q3 2023 | Q3 2023 | 1 | |
| ALKS | ALKERMES PLC | 1 | 1 | 0.79% | 0.79% | 0.79% | Q3 2023 | Q3 2023 | 1 |
| LGVW | LONGVIEW ACQUISITION CORP | 1 | 1 | 0.79% | 0.79% | 0.79% | Q4 2020 | Q4 2020 | 1 |
| AGLE | AEGLEA BIOTHERAPEUTICS... | 1 | 1 | 0.77% | 0.77% | 0.77% | Q2 2023 | Q2 2023 | 1 |
| NVCR | NOVOCURE LTD | 1 | 1 | 0.72% | 0.72% | 0.72% | Q4 2022 | Q4 2022 | 1 |
| FATE | FATE THERAPEUTICS INC | 1 | 1 | 0.70% | 0.70% | 0.70% | Q2 2022 | Q2 2022 | 1 |
| IOVA | IOVANCE BIOTHERAPEUTIC... | 1 | 1 | 0.70% | 0.70% | 0.70% | Q2 2022 | Q2 2022 | 1 |
| NUVALENT INC | 1 | 1 | 0.65% | 0.65% | 0.65% | Q3 2023 | Q3 2023 | 1 | |
| RUBY | RUBIUS THERAPEUTICS INC | 1 | 1 | 0.63% | 0.63% | 0.63% | Q1 2021 | Q1 2021 | 1 |
| PAND | PANDION THERAPEUTICS INC | 1 | 1 | 0.63% | 0.63% | 0.63% | Q4 2020 | Q4 2020 | 1 |
| CVAC | CUREVAC N V | 1 | 1 | 0.62% | 0.62% | 0.62% | Q4 2021 | Q4 2021 | 1 |
| GSK PLC | 1 | 1 | 0.62% | 0.62% | 0.62% | Q3 2022 | Q3 2022 | 1 | |
| CAPA | HIGHCAPE CAP ACQUISITI... | 1 | 1 | 0.61% | 0.61% | 0.61% | Q1 2021 | Q1 2021 | 1 |
| VSPR | VESPER HEALTHCARE ACQU... | 1 | 1 | 0.60% | 0.60% | 0.60% | Q4 2020 | Q4 2020 | 1 |
| CABA | CABALETTA BIO INC | 1 | 1 | 0.56% | 0.56% | 0.56% | Q2 2023 | Q2 2023 | 1 |
| ARKG | ARK ETF TR | 1 | 1 | 0.56% | 0.56% | 0.56% | Q4 2021 | Q4 2021 | 1 |
| BLUE | BLUEBIRD BIO INC | 1 | 1 | 0.51% | 0.51% | 0.51% | Q1 2021 | Q1 2021 | 1 |
| FXE | INVESCO CURRENCYSHARES... | 1 | 1 | 0.50% | 0.50% | 0.50% | Q3 2022 | Q3 2022 | 1 |
| ACRS | ACLARIS THERAPEUTICS INC | 1 | 1 | 0.50% | 0.50% | 0.50% | Q3 2023 | Q3 2023 | 1 |
| VRNA | VERONA PHARMA PLC | 1 | 1 | 0.47% | 0.47% | 0.47% | Q3 2022 | Q3 2022 | 1 |
| DRNA | DICERNA PHARMACEUTICAL... | 1 | 1 | 0.47% | 0.47% | 0.47% | Q4 2020 | Q4 2020 | 1 |
| UTHR | UNITED THERAPEUTICS CO... | 1 | 1 | 0.47% | 0.47% | 0.47% | Q3 2021 | Q3 2021 | 1 |
| AADI BIOSCIENCE INC | 1 | 1 | 0.45% | 0.45% | 0.45% | Q2 2023 | Q2 2023 | 1 | |
| CHAQ | CHARDAN HEALTHCARE ACQ... | 1 | 1 | 0.42% | 0.42% | 0.42% | Q4 2020 | Q4 2020 | 1 |
| DYN | DYNE THERAPEUTICS INC | 1 | 1 | 0.42% | 0.42% | 0.42% | Q4 2022 | Q4 2022 | 1 |
| CGEM | CULLINAN ONCOLOGY INC | 1 | 1 | 0.42% | 0.42% | 0.42% | Q2 2021 | Q2 2021 | 1 |
| ARAV | ARAVIVE INC | 1 | 1 | 0.38% | 0.38% | 0.38% | Q2 2023 | Q2 2023 | 1 |
| SIOX | SIO GENE THERAPIES INC | 1 | 1 | 0.37% | 0.37% | 0.37% | Q4 2020 | Q4 2020 | 1 |
| INO | INOVIO PHARMACEUTICALS... | 1 | 1 | 0.36% | 0.36% | 0.36% | Q4 2021 | Q4 2021 | 1 |
| RLAY | RELAY THERAPEUTICS INC | 1 | 1 | 0.36% | 0.36% | 0.36% | Q1 2022 | Q1 2022 | 1 |
| MIST | MILESTONE PHARMACEUTIC... | 1 | 1 | 0.35% | 0.35% | 0.35% | Q3 2022 | Q3 2022 | 1 |
| INSP | INSPIRE MED SYS INC | 1 | 1 | 0.35% | 0.35% | 0.35% | Q3 2023 | Q3 2023 | 1 |
| EYPT | EYEPOINT PHARMACEUTICA... | 1 | 1 | 0.35% | 0.35% | 0.35% | Q3 2023 | Q3 2023 | 1 |
| AUPH | AURINIA PHARMACEUTICAL... | 1 | 1 | 0.35% | 0.35% | 0.35% | Q1 2022 | Q1 2022 | 1 |
| ACRS | ACLARIS THERAPEUTICS INC | 1 | 1 | 0.34% | 0.34% | 0.34% | Q1 2023 | Q1 2023 | 1 |
| QSI | QUANTUM SI INC | 1 | 1 | 0.33% | 0.33% | 0.33% | Q2 2021 | Q2 2021 | 1 |
| MORF | MORPHIC HLDG INC | 1 | 1 | 0.32% | 0.32% | 0.32% | Q3 2023 | Q3 2023 | 1 |
| FGEN | FIBROGEN INC | 1 | 1 | 0.32% | 0.32% | 0.32% | Q2 2023 | Q2 2023 | 1 |
| SBTX | SILVERBACK THERAPEUTIC... | 1 | 1 | 0.30% | 0.30% | 0.30% | Q2 2022 | Q2 2022 | 1 |
| LYRA | LYRA THERAPEUTICS INC | 1 | 1 | 0.30% | 0.30% | 0.30% | Q4 2020 | Q4 2020 | 1 |
| OM | OUTSET MEDICAL INC | 1 | 1 | 0.30% | 0.30% | 0.30% | Q4 2020 | Q4 2020 | 1 |
| FXB | INVESCO CURRENCYSHARES... | 1 | 1 | 0.30% | 0.30% | 0.30% | Q3 2022 | Q3 2022 | 1 |
| CRSP | CRISPR THERAPEUTICS AG | 1 | 1 | 0.28% | 0.28% | 0.28% | Q4 2020 | Q4 2020 | 1 |
| BEAM | BEAM THERAPEUTICS INC | 1 | 1 | 0.28% | 0.28% | 0.28% | Q1 2022 | Q1 2022 | 1 |
| BLI | BERKELEY LTS INC | 1 | 1 | 0.27% | 0.27% | 0.27% | Q3 2021 | Q3 2021 | 1 |
| FOLD | AMICUS THERAPEUTICS INC | 1 | 1 | 0.27% | 0.27% | 0.27% | Q3 2021 | Q3 2021 | 1 |
| BHVN | BIOHAVEN PHARMACTL HLD... | 1 | 1 | 0.26% | 0.26% | 0.26% | Q3 2021 | Q3 2021 | 1 |
| ITOS | ITEOS THERAPEUTICS INC | 1 | 1 | 0.23% | 0.23% | 0.23% | Q2 2021 | Q2 2021 | 1 |
| PODD | INSULET CORP | 1 | 1 | 0.22% | 0.22% | 0.22% | Q3 2023 | Q3 2023 | 1 |
| BIOHAVEN LTD | 1 | 1 | 0.22% | 0.22% | 0.22% | Q3 2023 | Q3 2023 | 1 | |
| XFOR | X4 PHARMACEUTICALS INC | 1 | 1 | 0.22% | 0.22% | 0.22% | Q1 2021 | Q1 2021 | 1 |
| AVRO | AVROBIO INC | 1 | 1 | 0.22% | 0.22% | 0.22% | Q3 2023 | Q3 2023 | 1 |
| IPHA | INNATE PHARMA S A | 1 | 1 | 0.20% | 0.20% | 0.20% | Q3 2021 | Q3 2021 | 1 |
| VERV | VERVE THERAPEUTICS INC | 1 | 1 | 0.19% | 0.19% | 0.19% | Q3 2022 | Q3 2022 | 1 |
| ESPR | ESPERION THERAPEUTICS ... | 1 | 1 | 0.18% | 0.18% | 0.18% | Q1 2023 | Q1 2023 | 1 |
| VIR | VIR BIOTECHNOLOGY INC | 1 | 1 | 0.17% | 0.17% | 0.17% | Q2 2023 | Q2 2023 | 1 |
| ENOB | ENOCHIAN BIOSCIENCES INC | 1 | 1 | 0.16% | 0.16% | 0.16% | Q2 2022 | Q2 2022 | 1 |
| ISEE | IVERIC BIO INC | 1 | 1 | 0.15% | 0.15% | 0.15% | Q3 2022 | Q3 2022 | 1 |
| PROMIS NEUROSCIENCES INC | 1 | 1 | 0.15% | 0.15% | 0.15% | Q3 2023 | Q3 2023 | 1 | |
| EPZM | EPIZYME INC | 1 | 1 | 0.15% | 0.15% | 0.15% | Q1 2021 | Q1 2021 | 1 |
| KURA | KURA ONCOLOGY INC | 1 | 1 | 0.14% | 0.14% | 0.14% | Q3 2022 | Q3 2022 | 1 |
| MESO | MESOBLAST LTD | 1 | 1 | 0.14% | 0.14% | 0.14% | Q3 2023 | Q3 2023 | 1 |
| ATHX | ATHERSYS INC NEW | 1 | 1 | 0.14% | 0.14% | 0.14% | Q1 2022 | Q1 2022 | 1 |
| KROS | KEROS THERAPEUTICS INC | 1 | 1 | 0.12% | 0.12% | 0.12% | Q3 2021 | Q3 2021 | 1 |
| GLYC | GLYCOMIMETICS INC | 1 | 1 | 0.12% | 0.12% | 0.12% | Q1 2023 | Q1 2023 | 1 |
| PIRS | PIERIS PHARMACEUTICALS... | 1 | 1 | 0.10% | 0.10% | 0.10% | Q1 2023 | Q1 2023 | 1 |
| VXRT | VAXART INC | 1 | 1 | 0.08% | 0.08% | 0.08% | Q4 2020 | Q4 2020 | 1 |
| CVRX | CVRX INC | 1 | 1 | 0.08% | 0.08% | 0.08% | Q2 2021 | Q2 2021 | 1 |
| CALA | CALITHERA BIOSCIENCES INC | 1 | 1 | 0.06% | 0.06% | 0.06% | Q1 2022 | Q1 2022 | 1 |
| CRVS | CORVUS PHARMACEUTICALS... | 1 | 1 | 0.06% | 0.06% | 0.06% | Q3 2021 | Q3 2021 | 1 |
| WINT | WINDTREE THERAPEUTICS INC | 1 | 1 | 0.04% | 0.04% | 0.04% | Q1 2021 | Q1 2021 | 1 |
| BPMC | BLUEPRINT MEDICINES CORP | 1 | 1 | 0.02% | 0.02% | 0.02% | Q1 2022 | Q1 2022 | 1 |
| ARAV | ARAVIVE INC | 1 | 1 | 0.02% | 0.02% | 0.02% | Q2 2023 | Q2 2023 | 1 |
| ARAV | ARAVIVE INC | 1 | 1 | 0.01% | 0.01% | 0.01% | Q3 2023 | Q3 2023 | 1 |
| VCKAW | VICKERS VANTAGE CORP I | 1 | 1 | 0.01% | 0.01% | 0.01% | Q3 2022 | Q3 2022 | 1 |
Download | |||||||||
The securities at the top of the list , including MORPHIC HOLDING INC, KURA ONCOLOGY INC, and CELLDEX THERAPEUTICS INC NEW, are the highest-conviction holdings of Affinity Asset Advisors, LLC.
The conviction is calculated by counting the number of quarters a security has been reported by Affinity Asset Advisors, LLC. The higher the number, the higher the conviction and longer the holding period.
This page lists all the securities that Affinity Asset Advisors, LLC owns currently or has owned in the past.